NCT07070882View on ClinicalTrials.gov

Oral Steroid Taper After Total Knee Arthroplasty

PHASE1RecruitingINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

June 20, 2025

Primary Completion Date

June 20, 2026

Study Completion Date

June 20, 2027

Conditions
Osteoarthritis, Knee
Interventions
DRUG

Methylprednisolone

Patients will receive a tapered dose of methylprednisolone with the standard of care pain management

Trial Locations (1)

10032

RECRUITING

Columbia University Medical Center, New York

All Listed Sponsors
lead

Columbia University

OTHER